blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2620493

EP2620493 - Mesenchymal stem cells for the treatment of CNS diseases [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.02.2020
Database last updated on 29.01.2025
FormerThe patent has been granted
Status updated on  22.02.2019
FormerGrant of patent is intended
Status updated on  09.10.2018
FormerExamination is in progress
Status updated on  20.10.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Ramot at Tel Aviv University Ltd.
P.O. Box 39296
61392 Tel Aviv / IL
For all designated states
Brainstorm Cell Therapeutics Ltd.
12 Bazel Street
P.O. Box 10019 Kiryat Arie
49001 Petach-Tikva / IL
[2013/31]
Inventor(s)01 / Kadouri, Avinoam
4 David Avidan Street
49710 Petach-Tikva / IL
02 / Bar-Ilan, Avihay
14 Kitzis Street
69481 Tel-Aviv / IL
03 / Melamed, Eldad
44 Tagor Street
6934102 Tel-Aviv / IL
04 / Offen, Daniel
-
3895500 Kfar HaRoe / IL
05 / Sadan, Ofer
4/10 Alexander Penn Street
69641 Tel-Aviv / IL
06 / Bahat-Stromza, Merav
c/o Tzachi Stromza
209 Derech HaYam Street
34890 Haifa / IL
 [2013/31]
Representative(s)Dennemeyer & Associates S.A.
Postfach 70 04 25
81304 München / DE
[2019/13]
Former [2014/09]Dennemeyer & Associates S.A.
Poccistrasse 11
80336 München / DE
Former [2014/05]Speich, Stéphane, et al
Dennemeyer & Associates S.A.
55, rue des Bruyères
1274 Luxembourg-Howald / LU
Former [2013/31]Dennemeyer & Associates S.A.
55, rue des Bruyères
1274 Howald / LU
Application number, filing date13164650.726.05.2009
[2013/31]
Priority number, dateUS20080071970P28.05.2008         Original published format: US 71970 P
[2013/31]
Previously filed application, dateWO2009IL0052526.05.2009
[2013/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2620493
Date:31.07.2013
Language:EN
[2013/31]
Type: B1 Patent specification 
No.:EP2620493
Date:27.03.2019
Language:EN
[2019/13]
Search report(s)(Supplementary) European search report - dispatched on:EP28.06.2013
ClassificationIPC:C12N5/079, C12N5/0775, A61K35/28, A61P25/28
[2013/31]
CPC:
A61K38/185 (EP,US); A61K35/28 (EP,US); A61P25/02 (EP);
A61P25/28 (EP,US); C12N5/0618 (EP,US); C12N5/0662 (EP,US);
C12N5/0663 (EP,US); C12N5/0664 (EP,US); C12N5/0665 (EP,US);
C12N5/0666 (EP,US); C12N5/0667 (EP,US); C12N5/0668 (EP,US);
A61K35/12 (EP,US); C12N2500/84 (EP,US); C12N2501/01 (EP,US);
C12N2501/11 (EP,US); C12N2501/115 (EP,US); C12N2501/135 (EP,US);
C12N2506/1346 (US); C12N2506/1353 (EP,US); C12N5/0669 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/31]
TitleGerman:Mesenchymale Stammzellen zur Behandlung von Erkrankungen des Zentralnervensystems[2013/31]
English:Mesenchymal stem cells for the treatment of CNS diseases[2013/31]
French:Cellules souches mésenchymateuses destinées au traitement de troubles du SNC[2013/31]
Examination procedure22.04.2013Examination requested  [2013/31]
23.01.2014Amendment by applicant (claims and/or description)
11.04.2016Despatch of a communication from the examining division (Time limit: M04)
17.06.2016Reply to a communication from the examining division
11.10.2017Despatch of a communication from the examining division (Time limit: M02)
08.12.2017Reply to a communication from the examining division
10.10.2018Communication of intention to grant the patent
13.02.2019Fee for grant paid
13.02.2019Fee for publishing/printing paid
13.02.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09754337.5  / EP2285951
Divisional application(s)EP19155870.9  / EP3514229
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20090754337) is  19.04.2011
Opposition(s)03.01.2020No opposition filed within time limit [2020/11]
Fees paidRenewal fee
22.04.2013Renewal fee patent year 03
22.04.2013Renewal fee patent year 04
22.04.2013Renewal fee patent year 05
26.05.2014Renewal fee patent year 06
21.05.2015Renewal fee patent year 07
20.05.2016Renewal fee patent year 08
23.05.2017Renewal fee patent year 09
25.05.2018Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.05.2009
AT27.03.2019
CY27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
MK27.03.2019
MT27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
TR27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
[2022/31]
Former [2021/34]HU26.05.2009
AT27.03.2019
CY27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
MT27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
TR27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2021/32]HU26.05.2009
AT27.03.2019
CY27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
TR27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2021/26]AT27.03.2019
CY27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
TR27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/17]AT27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
TR27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/13]AT27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
LU26.05.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/07]AT27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/04]AT27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/03]AT27.03.2019
EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2020/01]EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
PL27.03.2019
RO27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/49]EE27.03.2019
FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
RO27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/48]FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/39]FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/38]FI27.03.2019
LT27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/37]FI27.03.2019
LT27.03.2019
SE27.03.2019
NO27.06.2019
GR28.06.2019
Former [2019/34]FI27.03.2019
LT27.03.2019
SE27.03.2019
NO27.06.2019
Former [2019/33]FI27.03.2019
LT27.03.2019
NO27.06.2019
Documents cited:Search[XDY]US2005265983  (MELAMED ELDAD [IL], et al) [XD] 1-6,11-13 * examples 2,6,16,20 * [Y] 7-10;
 [XDY]WO2006134602  (UNIV RAMOT [IL], et al) [XD] 1-6,11-13 * example 1 * [Y] 7-10;
 [XDY]WO2007066338  (UNIV RAMOT [IL], et al) [XD] 1-6,11-13 * example 3 * [Y] 7-10;
 [XY]  - BLONDHEIM N R ET AL, "Human mesenchymal stem cells express neural genes, suggesting a neural predisposition.", STEM CELLS AND DEVELOPMENT, (200604), vol. 15, no. 2, ISSN 1547-3287, pages 141 - 164, XP009079870 [X] 1-6,11-13 * the whole document * [Y] 7-10

DOI:   http://dx.doi.org/10.1089/scd.2006.15.141
 [Y]  - DOUCET C ET AL, "Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.", JOURNAL OF CELLULAR PHYSIOLOGY, (200511), vol. 205, no. 2, ISSN 0021-9541, pages 228 - 236, XP002545728 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.1002/JCP.20391
 [Y]  - BERNARDO M E ET AL, "Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.", JOURNAL OF CELLULAR PHYSIOLOGY, (200704), vol. 211, no. 1, ISSN 0021-9541, pages 121 - 130, XP002545729 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.1002/JCP.20911
 [Y]  - REINISCH A ET AL, "Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.", REGENERATIVE MEDICINE, (200707), vol. 2, no. 4, ISSN 1746-076X, pages 371 - 382, XP002545730 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.2217/17460751.2.4.371
 [Y]  - SCHALLMOSER K ET AL, "Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.", TRANSFUSION, (200708), vol. 47, no. 8, ISSN 0041-1132, pages 1436 - 1446, XP002553488 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.1111/j.1537-2995.2007.01220.x
 [Y]  - CAPELLI C ET AL, "Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts.", BONE MARROW TRANSPLANTATION, (200710), vol. 40, no. 8, ISSN 0268-3369, pages 785 - 791, XP002545732 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.bmt.1705798
 [Y]  - LANGE C ET AL, "Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.", JOURNAL OF CELLULAR PHYSIOLOGY, (200710), vol. 213, no. 1, ISSN 0021-9541, pages 18 - 26, XP002545733 [Y] 7-10 * the whole document *

DOI:   http://dx.doi.org/10.1002/jcp.21081
 [XP]  - SADAN O ET AL, "Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging.", STEM CELLS, (200810), vol. 26, no. 10, ISSN 1549-4918, pages 2542 - 2551, XP002545734 [XP] 1-6,11-13 * the whole document *

DOI:   http://dx.doi.org/10.1634/stemcells.2008-0240
 [XP]  - SADAN O ET AL, "Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.", THE ISRAEL MEDICAL ASSOCIATION JOURNAL, (200904), vol. 11, no. 4, ISSN 1565-1088, pages 201 - 204, XP002545735 [XP] 1-6,11-13 * the whole document *
 [A]  - WAGNER W & HO A H, "Mesenchymal stem cell preparations--comparing apples and oranges.", STEM CELL REVIEWS, (200712), vol. 3, no. 4, ISSN 1550-8943, pages 239 - 248, XP002545736 [A] 1

DOI:   http://dx.doi.org/10.1007/s12015-007-9001-1
 [A]  - GARCIA R ET AL, "Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20040409), vol. 316, no. 3, doi:10.1016/J.BBRC.2004.02.111, ISSN 0006-291X, pages 753 - 754, XP004495951 [A] 1

DOI:   http://dx.doi.org/10.1016/j.bbrc.2004.02.111
by applicantUS3791932
 US3839153
 US3850752
 US3850578
 US3853987
 US3867517
 US3879262
 US3901654
 US3935074
 US3984533
 US3996345
 US4034074
 US4098876
 US4666828
 US4683202
 US4801531
 US4879219
 US5011771
 US5192659
 US5272057
 US5281521
 US6528245
 WO2004046348
 US2005265983
 WO2006134602
 WO2007066338
    - GARCIA R ET AL., BIOCHEM BIOPHYS RES COMMUN., (2004), vol. 316, no. 3, pages 753 - 4
    - MEHTA V ET AL., J NEUROSURG, (199904), vol. 90, no. 4, pages 804 - 6
    - PARK, K., NEUROSCI. RES., (2001), vol. 40, pages 315 - 323
    - KOPEN, G.C. ET AL., PROC NATL ACAD USA., (1999), vol. 96, no. 19, pages 10711 - 6
    - SANCHEZ-RAMOS ET AL., EXP NEUROL., (2000), vol. 164, no. 2, pages 247 - 56
    - WOODBURY, D., J NEUROSCI RES., (2000), vol. 61, no. 4, pages 364 - 70
    - WOODBURY, D. ET AL., J NEUROSCI RES., (2002), vol. 69, no. 6, pages 908 - 17
    - BLACK, I.B.; WOODBURY, D., BLOOD CELLS MOL DIS., (2001), vol. 27, no. 3, pages 632 - 6
    - KOHYAMA, J. ET AL., DIFFERENTIATION, (2001), vol. 68, no. 4-5, pages 235 - 44
    - LEVY, Y.S., J MOL NEUROSCI., (2003), vol. 21, no. 2, pages 121 - 32
    - KASSIS ET AL., BONE MARROW TRANSPLANT., (200605), vol. 37, no. 10, pages 967 - 76
    - ZHANG ET AL., CHINESE MEDICAL JOURNAL, (2004), vol. 117, no. 6, pages 882 - 887
    - KERN ET AL., STEM CELLS, (2006), vol. 24, pages 1294 - 1301
    - WOODBURRY ET AL., J. NEURISCI. RES., (2001), vol. 96, pages 908 - 917
    - BLACK; WOODBURY, BLOOD CELLS MOL. DIS., (2001), vol. 27, pages 632 - 635
    - REYES; VERFATILE, ANN. N. Y. ACAD. SCI., (2001), vol. 938, pages 231 - 235
    - JIANG ET AL., NATURE, (2002), vol. 418, pages 47 - 49
    - REYNOLDS; WEISS, SCIENCE, (1992), vol. 255, pages 1707 - 1710
    - REYNOLDS; TETZLAFF; WEISS, J. NEUROSCI, (1992), vol. 12, pages 4565 - 4574
    - CHEN ET AL., CURR DRUG TARGETS., (200511), vol. 6, no. 7, pages 821 - 33
    - BENDOTTI, J NEUROCHEM, (2001), vol. 79, no. 4, pages 737 - 746
    - ULUDAG, H. ET AL., "Technology of mammalian cell encapsulation", ADV DRUG DELIV REV., (2000), vol. 42, doi:doi:10.1016/S0169-409X(00)00053-3, pages 29 - 64, XP002302229

DOI:   http://dx.doi.org/10.1016/S0169-409X(00)00053-3
    - LU MZ ET AL., "Cell encapsulation with alginate and alpha- phenoxycinnamylidene-acetylated poly(allylamine", BIOTECHNOL BIOENG, (2000), vol. 70, doi:doi:10.1002/1097-0290(20001205)70:5<479::AID-BIT1>3.0.CO;2-E, pages 479 - 83, XP008025769

DOI:   http://dx.doi.org/10.1002/1097-0290(20001205)70:5<479::AID-BIT1>3.0.CO;2-E
    - CHANG TM; PRAKASH S, "Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms", MOL BIOTECHNOL, (2001), vol. 17, pages 249 - 60
    - LU MZ ET AL., "A novel cell encapsulation method using photosensitive poly(allylamine alpha- cyanocinnamylideneacetate", J MICROENCAPSUL, (2000), vol. 17, pages 245 - 51
    - CHIA, S.M. ET AL., MULTI-LAYERED MICROCAPSULES FOR CELL ENCAPSULATION BIOMATERIALS, (2002), vol. 23, pages 849 - 56
    - SAMBANIS, A, "Encapsulated islets in diabetes treatment", DIABETES TECHNOL. THER., (2003), vol. 5, pages 665 - 8
    - CANAPLE L. ET AL., "Improving cell encapsulation through size control.", J BIOMATER SCI POLYM ED., (2002), vol. 13, pages 783 - 96
    - WILLIAMS D., "Small is beautiful: microparticle and nanoparticle technology in medical devices", MED DEVICE TECHNOL., (1999), vol. 10, pages 6 - 9
    - DESAI, T.A, "Microfabrication technology for pancreatic cell encapsulation", EXPERT OPIN BIOL THER, (2002), vol. 2, pages 633 - 46
    - FINGL ET AL., The Pharmacological Basis of Therapeutics, (1975), page 1
    - AUSUBEL, R. M.,, Current Protocols in Molecular Biology, (1994), vol. I-III
    - "Recombinant DNA", WATSON ET AL., Scientific American Books
    - BIRREN ET AL., Genome Analysis: A Laboratory Manual Series, COLD SPRING HARBOR LABORATORY PRESS, (1998), vol. 1-4
    - CELLIS, J. E.,, Cell Biology: A Laboratory Handbook, (1994), vol. I-III
    - COLLIGAN J.E.,, Current Protocols in Immunology, (1994), vol. I-III
    - Methods in Enzymology, ACADEMIC PRESS, vol. 1-317
    - PARFITT ET AL., "Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee", J BONE MINER RES, (1987), vol. 2, no. 6, pages 595 - 610
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.